Feiya Du

miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4

Feiya Du, Ling Yu, Ying Wu et al. · Cell Death and Disease · 2019 · 71 citations · Full text

Medicine, Oncology, Pharmacology +16

Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines

Peifen Fu, Feiya Du, Wei Chen et al. · Oncology Reports · 2014 · 47 citations · Full text

Medicine, Cancer Biology, Oncology +17

microRNA-375 inhibits osteogenic differentiation by targeting runt-related transcription factor 2

Feiya Du, Huiling Wu, Zhiqin Zhou et al. · Experimental and Therapeutic Medicine · 2015 · 44 citations · Full text

Medicine, Oncology, Bone Metabolism +16

Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin

Yu Liu, Feiya Du, Wei Chen et al. · Experimental Cell Research · 2013 · 40 citations

Medicine, Cell Biology, Oncology +11

MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells

Peifen Fu, Feiya Du, Minya Yao et al. · Experimental and Therapeutic Medicine · 2014 · 34 citations · Full text

Medicine, Molecular Biology, Oncology +17